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-IntroductionVitamin K is one of the more recent additions to
the slowly unraveling vitamin complex, and takes its
place in the fat soluble group along with vitamins A
and D.

The vitamin K complex has not as yet been thor-

oughly investigated, but already there has been isolated
vitamins Kl, K3 and K4 and these substanees are being
used clinically.
The story of vitamin K is interesting because of
its accidental discovery almost simultaneously in three
independent laboratories, and its rapid development
since that time.

It is interesting because of its great

import to serious cholemic hemorrhage which, though not
of high incidence, has been a serious problem confronting surgeons for many years.

It is interesting because

it means the prevention and cure of hemorrhage of the
newborn, a condition which has never been well understood and a serious problem to pediatricians for years.
In presenting this subject, I have considered the
experimental work because it is essential to an accurate
understanding of vitamin K therapy.

Much of the mater-

ial in the first section of the story has no practical
value, but it is essential in arriving at certain conclusions concerning indications for vitamin K therapy.
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Discovery or Vitamin K
In 1929, Henrik Dam (1), working in the laborato-

ries of the University of Copenhagen, began studies of
the sterol metabolism or the chicken.

During the course

of investigation he observed that chicks fed on a fatfree diet for two or three weeks had a marked tendency
to large subcutaneous and intramuscular hemorrhages and
certain pathological changes in the stomach.

He further

noted that in all cases the growth was subnormal, and
that in one chick
markedly increased.

the clotting time of the blood was
Dam demonstrated at that time that

the low content or sterol and rat in the diet was of no
importance because the addition of cholesterol and cod
liver oil did not prevent the symptoms.
Also in the year 1929, Roderick (2), working for
d

the United States Government, was sent out to discover
the cause of "sweet clover disease" in cattle.

He found

that cattle fed on spoiled sweet clover hay were prone
to develop fatal hemorrhage during the dehorning process.
The disease is characterized by the development of a
gradually increasing prolongation of the time required
for the blood of the animals to coagulate when it is
drawn into tubes or in the bleeding times of injuries
and wounds.

Examination of the cattle that died reveal-

ed a central liver necrosis.

He observed further that
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all cattle that obtained alfalfa in addition did not develop these hemorrhages, thereby making it evident that
the sweet clover acquires specific disease-producing
properties when it spoils in the curing process.

In his

subsequent analytical work, Roderick showed that the delayed coagulability of the blood in "sweet clover disease" involves a reduction in the plasma prothrombin and
that the diminution parallels the delay in the coagulation time.
Apparently independently, other laboratories observed the hemorrhagic chick disease in the three years
from 1931 to 1933 (3,4,5).

As in the case of Dam's dis-

covery, the finding was an incidental one, noted in the
course of experiments in which chicks were fed purified
diets low in fats.

In 1931, while studying the effect

of various proteins on chick growth, McFarlane, Graham
and Hall (3) similarly noted spontaneous hemorrhages in
their chicks.

This hemorrhagic tendency was observed in

the same laboratory by McFarlane, Graham and Richardson
(4) in their work on the fat-soluble vitamin requirements of the chick.

In both instances a prolonged blood

clotting time was noted but could not be explained by
these workers.
It was considered originally that the hemorrhagic
syndrome was due to sou:rvy, despite earlier reports that
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chicks are able to synthesize vita.min C.

Subsequent

studies, however, served to rule out scurvy as well as
other lmown vitamin deficiencies.

Dam's experiments (1)

clearly show that ascorbic acid does not prevent the development of the hemorrhagic syndrome and the cause of
the disease cannot be a diminished absorption of vitamin
C from the intestine or a diminished production of the
vitamin in the organism since subcutaneous injections of
ascorbic acid were ineffective.

It nmst be considered

unlikely that the factor is vitamin A or D because a
relatively large supply of cod liver oil was added to
the basal diet of the chicks (l,3,4,5) without any
noticeable change in the symptoms.

Symptoms of poly-

neuritis or pellagra were never observed in connection
with these diets (1,5), thus rendering it unlikely that
the syndrome is due to a deficiency of vitamin Bl or B2.
The exclusion of vitamin E was made by Dam (6) when he
added large quantities of wheat germ and wheat germ oil
to the basal diet and found that they did not afford
complete protection against the disease.

As a result of

these experimental findings, it was first suggested by
Dam in 1934 (1) that this hemorrhagic condition observed
in chicks was a new dietary deficiency disease which he
believed was due to an unlmown substance lacking in the
fat-free diet that was essential for the proper coagula-
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tion of the chick's blood.

Since the Danish word for

coagulation is spelled "Koagulation", Dam named this unknown substance vitamin K, a terminology which has been
adopted generally.
It has been mentioned that the basal diets which
were employed by Dam (1,6), McFarlane and his coworkers
(3,4) and Holst and Halbrook (5) in their respective
studies, and which caused the hemorrhagic chick disease,
were. low in fat content.

However, the first definite

evidence of the fat-soluble nature of the vitamin is
found in the early work of McFarlane, Graham, and Richardson (4).

They discovered that chickens fed on a diet

containing ether-extracted fish meal suffered from the
hemorrhagic tendencies, but that those fed on unextracted
fish meal did not suffer the hemorrhages.

Later Almquist

and Stokstad (7) showed that fish meal and yeast, both
of which form large parts of many of the hemorrhage-producing purified diets, contain traces of the vitamin.
The ether extraction of these substances before their
incorporation in the basal diets is now perfonned for the
successful production of the disease.

In the summer of

1935, first Dam (6) and later Almquist and Stokstad (7),
obtained concentrates of the vitamin from natural sources
by ether extraction, thus establishing the fat-soluble
nature of the vitamin.

These workers first used purified
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fish meal and hog-liver fat as natural sources of the
vitamin concentrate, describing it as occurring in the
easily soluble non-sterol fraction of the unsaponifiable
matter.
Following the recognition of the hemorrhagic chick
disease as a nutritional disorder, the relationship of
this new dietary factor to blood clotting was soon established.

The characteristic prolonged clotting time

incident to the disease had been observed by the original workers (1,3,5), but it was Schpnheyder in 1936 (8)
who first suggested that the hemorrhagic tendency is the
result of a hypoprothrombinemia.

Shortly thereafter,

he, in collaboration with Dam and Tage-Hansen (9) of
Copenhagen, published results of their studies on the
mode of action of vitamin K and provided evidence which
definitely pointed to a lowered prothrombin level in the
hemorrhagic chick disease.

They first obtained crude

prothrombin preparations from normal chick plasma by
acetone precipitation and by acetic acid precipitation.
Added to a mixture of K-avitaminous chick plasma and
thromboplastic muscle extract, the prothrombin preparations corrected the clotting defect.

On the other hand,

similar preparations from K-avitaminous chick plasma were
without effect.

Also, addition of a watery emulsion of

a vitamin K concentrate to the plasma-thromboplastin
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mixtures tailed to restore the clotting time to normal.
From this they concluded that the clotting abnormality
was due to a low plasma prothrombin level, and that
vitamin K itself did not possess prothrombic activity.
A more detailed study ot the prothrombin in hemorrhagic chick disease was carried out by Quick (10) in
1937.

On a series of chicks maintained on a vitamin K-

deticient diet, he estimated the plasma prothrombin time
at various intervals throughout the course ot the disease.

The progressive tall ot prothrombin as the dis-

ease progressed is shown 1n the following data taken
from his experiment:
Days on K-detioien t diet.

Prothrombin, per cent
ot normal chicks.

1
4
8
11
15

100

18

40

22
19
18
10

A distinct hemorrhagic tendency appeared when the low
prothrombin levels were reached.

The addition of a

small amount ot alfalfa meal (5$) to the basal diet effectively restored the plasma prothrombin and cured the
hemorrhagic tendency.
Following this important study by Quick, rapid advances in our general knowledge of vitamin K were made
in various laboratories by further experimental efforts.
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-Vitamin K Deficiency in Experimental AnimalsThe study of vitamin K de fie iency in chicks has
served as the source of a great part of our present concept of the vitamin, its chemical constitution and mode
of action in the organism.

Recent findings of the re-

search laboratories are important because of their
practical application to certain disease states in the
human, which will be discussed later.
From Quick 1 s study of the plasma prothrombin level
in hemorrhagic chick disease (10), and later studies of
a similar nature (11), it was determined that hemorrhages do not occur until the prothrombin has declined
to approximately ten to fifteen per cent of normal.

In

the development of the disease, the appearance of hemorrhage is preceded regularly by a prolongation of the
clotting time of the whole blood.(12).

Tidrick, Joyce

and Smith (11) made a detailed study concerning the rate
at which the plasma prothrombin level falls when newly
hatched chicks are placed on a vitamin K-deficient diet.
They found that the whole blood clotting time becomes
prolonged when the prothrombin level falls to about
of the norm.al level for chicks of the same a.ge.

30~

Thus,

early 1n the course of the disease when the vitamin deficiency is less severe, the plasma prothrombin may be
reduced considerably and the clotting time still be
within normal limits.

It would appear that plasma pro-
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thrombin determinations are essential if any but the
more severe grades of deficiency are to be detected.
The production of the hemorrhagic chick disease is
dependent on the complete removal of vitamin K from the
diet, because the presence of minute traces will prevent
the development of a severe deficiency.

It has been

pointed out previously that both fish meal and yeast,
which comprise a large part of almost all basal diets,
contain traces of the antihemorrhagic factor (7), and
that this led to the ether extraction of these substances before their incorporation in the diet.

The

original diet employed by Dam (1) contained no fish meal
and was an artificial diet consisting of vitamin A-free
caseinogen, 20 parts; marmite, 10 parts; soluble starch,
65.5 parts; salts, 4.5 parts; plus varying amounts of

cod liver oil concentrates.

The diet finally used by

Almquist and Stokstad (7) and widely adopted by other
investigators consists of the following:
Fish meal, extracted with ether
Brewer's yeast, extracted with ether
Ground polished rice
NaCl, plus ferrous and cupric sulfates
Cod liver oil

17.5 parts
7.5 parts
73.0 parts
l.O part
l.O part

This diet probably contains a minimal amount of vitamin

K, since Almquist (13) noted the hemorrhagic chick disease in chicks on this diet as early as the fifth day
after hatching, the average appearance of hemorrhagic
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s-ymptoms being about the third week.

Nevertheless, it

was repeatedly observed that a certain number

or

chicks

railed to develop hemorrhages or prolonged clotting
times during a rour-week period on the diet (14)
Recognition

or

the synthesis of the vitamin by

bacteria was first reported by Almquist and Stokstad (7)
1n their earlier work.

They later showed that rice bran,

fish meal and other foods which had been stored in a
moist condition developed vitamin K activity (14), and
that the incorporation of these substances in the basal
diet prevented the development of the hemorrhagic chick
disease.

They also demonstrated the curative effect of

putrified fish meal on vitamin K-deficient chicks with
definite hemorrhagic s-ymptoms (15), indicating that the
bacterial growth produced enough vitamin K to restore
the chick to normal.

Almquist, Pentler and Mecchi (15)

in 1938 found several different types of bacteria in the
putrified material and isolated one strain in pure culture.

They inoculated this organism to wet, sterile,

ether-extracted fish meal and found that it had a potent
curative action on K-avitaminous chicks after a ten-day
period of incubation.

Putrefying fish meal was used

subsequently by Osterberg and various other workers as a
potent source of vitamin K.
In addition to the possibility of production of the
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antihemorrhagic factor in the diet by bacterial putrifaction of the food, other factors influencing the incidence of this dietary hemorrhagic disease must be considered.

Almquist and Stokstad (16) discovered that the

vita.min is present in the fecal matter of the chicks,
even though they may be held on a vitamin K-free diet
for a long period of time.

They believed the vitamin to

be produced in the lower portion of the intestine, too
low for absorption, since many of the chicks were suffering the disease in the presence of synthesis of the
vita.min within the body.

Because of the vitamin K con-

tent of the feces, these workers found it necessary to
prevent coprophagy among the chicks in order to produce
the disease successfully.
In the early experiments with vitamin K deficiency,
Holst and Halbrook (5) and Almquist and Stokstad (7)
noted that the severity of the disease increased with
the rapidity of groi.vth of the chick.

Another factor in-

fluencing the development of the disease, also suggested
by Almquist and Stokstad {16), is the transfer of the
antihemorrhagic vitamin from the diet of the hen to her
chick.

This transfer is apparently carried out through

the yolk of the egg, and the vitamin is then stored up
in the body of the chick in sufficient quantities to
protect against a K-free diet for a period of about two
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weeks.

Experiments were carried out in which two series

of chicks were maintained on a K-free diet with supplements of egg yolk and egg albumen, respectively, for two
or three weeks.

It was found at the end of that period

that the yolk supplements to the basal diet had protected against the development of the chick disease, while
the egg albumen supplements had not protected.

This

suggests the possibility that some hens may receive a
larger supply of vitamin K in their diet and thereby
transfer a greater protection to their chicks.
Seasonal variations in the vitamin reserves of the
chicks probably occur, as green plants are the moat
potent food source of the vitamin (1).

Thia would ex-

plain the observations of Thayer and associates (17)
that the chick deficiency is most severe in the late
winter and early spring months, and of Tidrick, Joyce
and Smith (11) that normal chicks have a higher prothrombin level in the summer than in the late tall.
Even if the factor of varying reserves is controlled, individual variations in the susceptibility of
chicks to the deficiency have been reported by Almquist
and his associates (14).

They also demonstrated that

although bile acids are important in the absorption of
the vitamin, their administration failed to erase these
individual differences.

The discovery of so many factors
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influencing the production of the disease is important
in explaining away inconsistencies and failures to produce the disease experimentally, thus definitely establishing the role of the vitamin as a necessary dietary factor for normal chicks.
In regard to the experimental production of hemor-

rhagic disease in mammals by dietary measures alone, it
may be said that, in general, they have not been success:f'u.l.

Dam,

Sch~nheyder

and Lewis (18) fed young rats,

quinea pigs, rabbits, dogs and pigs a K-deficient diet
for a period of two and a half months and obtained no
evidence of the disease.

They concluded that the fact

that certain species of animals can apparently dispense
with vitamin K in their diet may be explained in one of
three different ways: (l) The animal has no need of the
vitamin, (2) the animal can synthesize the vitamin, or
(3) the vitamin is synthesized by bacteria in the intestine.

The last was accepted as the most likely ex-

planation because of the previous report of Almquist and
Stokstad (16) that provided evidence for the view that
bacterial synthesis of vitamin K occurs in the gut of
the chick, and that it may be the reason why, under
certain conditions, the development of the symptoms of
the chick may be retarded.

It is a lmown fact that ab-

sorption from the lower part of the intestine is much
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greater in the mammal than in the chick and, on this
basis, Dam and his asaocia es concluded that mammals
rarely show vitamin K defi iency except in cases of
faulty absorption from the intestine.
It is interesting to

ote that as early as October

of 1935 Quick, Stanley-B

and Bancroft (19) proved

conclusively that plasma p othrombin was definitely decreased in persons sutferi

from obstructive jaundice.

Since he had observed an e evation of plasma prothrombin
levels in the hemorrhagic

hick disease by administration

of vitamin K ( 10), Quick p oposed the use of the vitamin
in obstructive jaundice o

theoretical grounds, though

he had no direct tests

the validity of his pro-

posal.

the idea that the de-

His theory was

pletion of prothrombin in obstructive jaundice may be
due to the absence of bil
thus causing a faulty abs

acids in the intestinal tract,
of vitamin K.

Since Quick (19) had already called attention to
the low prothrombin level in jaundice, Hawkins and Brinkhous (20) undertook

luate the prothrombin concen-

tration in dogs after est blishing biliary fistula.

They

found that the plasma pro hrombin was at an extremely
low level at the time of

pontaneous bleeding, often

falling to less than five per cent of a normal control
dog.

The whole blood clo ting time, which was prolonged,
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was restored to normal by the addition of a partially
purified prothrombin, free of calcium and thromboplastin.

Normal values for serum calcium and plasma

fibrinogen were obtained, and there was no evidence of
an excessive amount of antithrombin or of heparin. These
data show definitely that the hemorrhagic tendency was
the result of a prothrombin deficiency, and it was
demonstrated that bile feeding prevented as well as
cured this bleeding tendency.

Further studies in 1938

by Smith, Warner, Brinkhous and Seegers (21) showed that
in the hemorrhagic disease of biliary fistula dogs the
critical prothrombin level at which bleeding is likely
to occur is approximately ten per cent of normal.
Though the work just cited definitely proved the
existence of prothrombin deficiency in biliary fistula,
the first direct evidence in support of Quick's theory
concerning the role of bile acids in the absorption of
vitamin K was supplied by Greaves and
(22).

Sch.~idt

in 1937

These workers made observations on a group of

operative biliary fistula rats and a group of unoperated
rats maintained on a low fat diet for a period of 30-50
days.

The bile fistula rats, at the end of this time,

showed a marked increase in the coagulation time of the
blood, while the unoperated rats were entirely unaffected.

Small scratches of the skin or clipping of the tail
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of these bile fistula animals led to prolonged bleeding,
often resulting in death unless stopped by the application of collodion.

Blood studies showed that the pro-

thrombin content of the animals was reduced to 20-30 per
cent of normal before coagulation time was markedly increased.

In order to rule out a deficiency of any other

dietary factor as a possible cause of this condition,
vitamins A, B, D, E and G, the essential fatty acids,
and lemon juice at levels of two cubic centimeters were
added to the basal diet.

No alteration of the hemor-

rhagic condition was observed after these supplements.
However, when two to three cubic centimeters

of beef

bile were fed daily, a marked rise in the prothrombin
content of the blood was noted within a period of two to
four days after the bile was administered.

Also, crude

extracts of vitamin K (prepared from alfalfa) which had
proven effective in preventing the hemorrhagic syndrome
in chicks, when fed to the bile fistula rat, were effective 1n decreasing the coagulation time of the blood
and increasing the prothrombin level.

In a similar

study of bile fistula and jaundiced rats 1n 1939,
Greaves (23,24) concluded that the marked bleeding tendency in these conditions, associated with an increased
bleeding time and a low blood prothrombin value, is the
result of vitamin K deficiency and can be cured by the
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administration of vitamin K concentrates.

They demon-

strated that bile salts are essential to the intestinal
absorption of vitamin K in the rat; that is, the bile
acts as a carrying agent for the vitamin across the
intestinal tract.
With attention drawn to the fact that vitamin K
appeared to be necessary for the formation of prothrombin, it became necessary to determine the source of
prothrombin within the organism.

Smith, Warner and

Brinkhous (25) and Quick (10) in 1937 proved the source
of prothrombin to be in the liver.

By using chloroform.

they caused a liver necrosis in dogs and were able to
sL'1lulate the hemorrhage that occurred in "sweet clover
disease" of cattle, the condition which Roderick (2) investigated several years before and found to have an
associated liver damage.

These workers found that the

bleeding tendency in this toxic liver disease was the
result of a prothrombin deficiency.

In several experi-

ments of this type, platelets, antithrombin, and calcium
studies showed normal or nearly normal values, thus
demonstrating in a striking way that prothrombin deficiency can give rise to a bleeding tendency.

They

concluded from this study that the relation of the liver
injury to plasma prothrombin level in this disease indicates that the liver is concerned in the manufacture
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of prothrombin.

Basing his views on these findings,

Quick again advocated the use of vitamin K in treatment
of biliary obstruction.
Approximately two months after Hawkins and Brinkhous (20) first published the results of their experiments on biliary fistula dogs, the first successful
treatment of human patients with obstructive jaundice
was reported from the same laboratory (26).

Other clin-

ical evidence lent its support when Butt, Snell and
Osterberg at the Mayo clinic successiUlly demonstrated
that postoperative bleeding 1n gall bladder surgery was
minim.ized by the use of vitamin K.

These reports of

treatment of human cases will be considered in a later
section.
•Sources ot Vitamin KThe first indication ot vitamin K occurring 1n
nature was given by Dam in his original investigations

ot the hemorrhagic chick disease.

He demonstrated that

the hemorrhagic syndrome could be prevented by the addition ot mixed cereals to the basal diet.

In later ex-

periments designed to determine the distribution ot the
vitamin (6), he found that one of its richest sources is
hog-liver fat.

He :tUrther showed that hemp seed and

alfalfa are particularly protective against the disease,
while unpolished rice, sunflower seed, yellow corn and
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rye are nearly valueless.

Certain vegetables such as

tomatoes, kale, orange peel and spinach appeared to have
a fairly good action against the disease.
Almquist and Stokstad (7) reported 1n 1935 that the
addition of 0.5 per cent of dry alfalfa to the deficient
diet prevented the appearance of symptoms, and from that
time alfalfa has been one of the main sources of vitamin
K concentrates.

Recognition of a different antihemor-

rhagic factor resulted from the observation of Almquist
and Stokstad (16) that rice bran, fish meal and other
foods which had been stored in a moist condition developed vitamin K activity.

That this production was

due to the action of micro-organisms was definitely concluded from Osterberg's work (27), which showed that
large amounts of an antihemorrhagic substance were produced by bacterial putrifaction of fish meal.
Almquist, Pentler and Macchi {15) continued the
study of bacterial synthesis of vitamin K and found that
the putrifaction of ether-extracted, K-free fish meal
was accompanied by the formation of appreciable amounts
of a fat-soluble, antihemorrhagic substance.

Several

different types of bacteria were present in the putrified material.

One organism producing a similar putri-

f action was isolated in pure culture and inoculated to

beef broth, fish-meal broth, proteose-peptone broth,
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gelatin and nutrient agar.

Washed bacteria from broth

and from nutrient agar were found to be rich sources of
the ant1hemorrhagic factor, while the liquid media from
which the bacteria had been removed by filtration, and
saline used in washing the bacteria, were negative.
They further demonstrated, by administering dried
bacteria of several species to K-deficient chicks, that
the antihemorrhagic activity of these organisms was from
five to eight times that of dried alfalfa.

1hey con-

cluded that this factor is the product of bacterial
metabolism, and, though it is also extractable by fatsolvents, its .further similarity to the vitamin K from
alfalfa v1as not established.
The most extensive study of the distribution of
vitamin K in the vegetable kingdom was carried out by
Dam and Glavind (28) in 1938.

In accordance with pre-

vious results, they found green leaves to be the most
potent source of vitamin K among the plants.

Among the

species examined, chestnut leaves were the most potent.
Those lower plants which contained chlorophyll appeared
to be somewhat poorer sources than the higher plants.
11he mushroom, which contains no chlorophyll, was very
poor in vitamin K content.

Leaves of the chestnut were

found to lose only a small portion, if any, of their
vitamin K activity when their chlorophyll disappeared
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during the withering process.

An experiment with germ-

inating peas showed that whereas there was an abundant
synthesis of the vitamin in peas grown in the light,
synthesis in peas grown in the dark occurred to a very
limited extent.

Any relationship between vitamin K and

chlorophyll was not explained by Dam and Glavind.
However, in more recent studies of substances with
vitamin K activity, designated vitamins Kl and K2,
Fieser and his associates (29) have pointed out the
noticeable presence of large amounts of the vitamin in
those parts of the plant containing chlorophyll.

This

fact has led Fieser to postulate that vitamin Kl contains, like chlorophyll, a phytyl group.

He has sug-

gested that Kl arises in nature by the condensation of
phytol and 2-alkyl-l,4-naphthohydroquinone, both of
which occur in plants.

Fieser (29) has .further suggest-

ed that since both vitamins El and Kl contain a phytyl
group, it is possible that there may be a close biogenetic relationship between the two.
It is now generally agreed (30) that the substances
which contain the antihemorrhagic property in the order
of potency are: (1) Putrefied fish meal, (2) alfalfa,
(3) hog-liver fat, (4) kale, (5) spinach, (6) dried
carrot tops, (7) chestnut leaves, (8) tomatoes, (9) oat
sprouts, (10) soy beans, and (11) the naphthoquinones.
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-BioassayThe methods for assay of vitamin K are based on the
prevention or cure of vitamin K deficiency in chicles.
The criteria used for the detection of the disease have
varied with different investigators and have been changed
by the same investigator from time to time.

Hemorrhage

was first used as the measure of deficiency but as it
only occurs when the prothrombin level has fallen to 1015 per cent that of normal chicks (10,11), only the most
severe deficiencies are detected by this symptom.

Pro-

longation of the blood clotting time was later used as a
measure of deficiency, but we now know that a moderate
deficiency may exist and the clotting time be normal.
It is prolonged only if the prothrombin level of the
blood is below about 30 to 40 per cent that of the normal
chick (11).

Dam and Glavind (31) used R-values to in-

dicate the extent of the deficiency.

These values de-

pend on the amount of thromboplastin required to give a
constant clotting time of three minutes.

Almquist and

Klose {32) recently adopted a prothrombin time measurement which they believe is a great improvement over the
clotting time tests.

In view of the findings of Tidrick,

Joyce and Smith (11), the use of the two-stage method
for prothrombin determination would appear to give an
even more accurate index of vitamin K deficiency.
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A large number of curative and preventative procedures for the assay of vitamin K have been devised.

Each

investigator has proposed an individual technique for
the standardization of the
considerable detail.

vita.~in,

all of which entail

For this reason only the results

of these assays will be considered here, so that a comparison of the various accepted standards may be made.
The Dam unit of activity (31) refers to a special
preparation of dried spinach, to which a value of 500
units per gram has been arbitrarily assigned.

'IWo mg.

of this product therefore constitutes one unit.

When

2 mg. of this standard preparation per gram of body
weight is given daily to a highly K-deficient chick on
three successive days, normal blood clotting is obtained.
Dan.n's method (33,34) is that of giving varying
levels of the test material to a group of K-deficient
chicks fro three successive days, and at the same time
treating another group of deficient chicks with a
standard vitamin K concentrate prepared from alfalfa, to
which has been assigned arbitrarily a value of 5000
vitamin K units per gram.

By comparing the blood clot-

ting times obtained by feeding the unlmown and the
standard, the vitamin K unitage of the test material is
determined.

This would indicate that her unit of vita-

min K is the amount of material, based on the standard
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of known potency, which when administered to chicks
daily will bring about a coagulation time of the blood
equal to that produced by the reference standard under
the conditions of the test.
Ansbacher (12) has defined his unit of vitamin K as
"the minimum amount necessary to render the blood clotting time of the vitamin K-deficient chick, weighing 70
to 100 grams, nonn.al within six hours after administrationrr.

The material to be tested for vita."nin K activity

is introduced directly into the crop, and it is fed in
different dosage to several groups of five or more
chicks to determine this minimum level.
Thayer and his assoviates (35,36) define a unit of
vitamin K as

11

that quantity of vitamin (K) which pro-

duces a clotting time of ten minutes or less in 50 per
cent of a group of ten or more chicks which has been fed
for the fourteen days immediately following receipt from
the hatchery on a diet practically devoid of vitamin K11 •
Almquist and Klose (32) have also presented a
method of assay of vitamin K, showing that nthe reciprocal of the mean blood clotting time and of the mean prothrombin

tL~e

bears a linear relation to the logarithm

of the vitamin K level in the diet over a practical
range of lave ls rt •
In a report to the Council of Pharmacy and Chemistry
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of the American Medical Association in 1939, Snell and
Butt (37) reviewed the work done on assay of vitamin K
and pointed out that there is not complete agreement
among the investigators working in this field as to the
manner of defining a unit or as to the best methods of
assay.

Since they felt that any attempt to arbitrarily

establish a universal unit of vitamin K would be unlikely to suit all investigators, it was suggested at that
time that a consideration of units be postponed until
exact and final knowledge of the chemical structure of
vitamin K be known.
In a more recent report of the status of vitamin K,
Brinkhous (30) has attempted to correlate the various
units of vitamin K.

He tabulated the following compar-

ative values, which he states must be considered only as
rough approximations because of discrepancies in the
several methods of assay already referred to in the
foregoing paragraphs.
1 Ansbacher unit equals 20 Dam-Glavind units.
1 Thayer-Doisy unit equals 30 Dam-Glavind units.
1 Dann unit equals 25 Da.m-Glavind units.
100-150 Thayer-Doisy units per kilo of diet are
protective by the method of Almquist, Mecchi
and Klose (14,32).
The discovery in 1939 (38) of pure naphthoquinone
compounds possessing vitamin K activity brought the previous proposal of Snell and Butt (37) nearer to realization.

In line with the suggestion of these men, Thayer
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and his associates (38) proposed that one of the simplest
and most potent of the naphthoquinones, 2-methyl-1,4naphthoquinone, be adopted as a standard in chick assay
work, and all other materials be ex.pressed in terms of
the activity of one microgram of this compound.

This

would simplify considerably the individual unit systems
used at present by various investigators, and at the
same time it would provide a common standard on which
all experimental and clinical study could be based.
-Chemistry of Vita.min Kl. Properties.

In earlier work on the purification of

vitamin K, Dam (6) and Almquist and Stokstad (7) observed that the antihemorrhagic factor is extractable from
natural sources by fat solvents.

Attempts at isolation

of the vita.min showed that it occurs in the non-sterol
fraction of the lipids.

They found that the vitamin is

insoluble in water and methyl alcohol but soluble in
many of the common organic solvents.

Both acetone and

petroleum ether proved to be satisfactory for the extraction of the vitamin from natural sources.
Following the discovery in 1935 by Almquist and
Stokatad (7) that dried alfalfa leaf meal is an excellent source of vita.min K, they prepared the first crt.ide
concentrate of the vitamin by extraction with petroleum
ether.

Fractionation with solvents proved ineffective
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in the separation of the pure vitamin.

Likewise, chem-

ical reactions on the crude product accomplished little,
except to show that certain common procedures could not
be employed.

Dam and Sch¢nheyder (39) and Almquist (40)

found that saponification of the vitamin concentrates
with alkali resulted in destruction of a large part of
their activity, proving a lability of the vitamin toward
alkali.
In addition to being alkali-labile, Almquist (41)
discovered that the vitamin is destructed by ultraviolet light.

He reported a destruction of the vitamin

activity of alfalfa concentrates within two hours after
exposure to sunlight, whereas no alteration was observed
in artificial light (500 watt lamp) up to 24 hours.
MacCorquodale and his associates (42) confirmed the
effect of sunlight reported by Almquist, but in addition
found that highly purified preparations of vitamin K
dissolved in various solvents rapidly lose activity on
exposure to the illumination of ordinary daylight bulbs.
They :rurther observed that crude extracts of alfalfa are
quite stable, no special precautions regarding light
being necessary, but as the potency is increased to 500
and 1000 units (Thayer units) per mgm., the lability is
such that decomposition may occur in spite of all precautions regarding light.
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One property of vita.min K, namely thermostability,
has proved to be quite important, since it led Almquist
(43) to introduce molecular distillation for the purpose of purification.

He observed that the vitamin in

concentrates of alfalfa or hog-liver fat resists heating
up to 120 degrees C. for twenty-four hours.

Dam and

Lewis (44) prepared a concentrate from alfalfa which
they found to be resistant to treatment with acetic anhydride at 100 degrees C. for one-half hour.

It was

also noted that the vitamin is adsorbed on strong adsorption media such as aluminum. oxide and magnesium
oxide, resulting in destruction of activity.
In a more detailed study in 1938, Klose, Almquist
and Mecchi (45) demonstrated that the vitamin is destroyed by oxidizing agents, strong acids and aluminum
chloride, and in reactions which eliminate ethylenic
linkages.

Irreversible loss of activity due to bromin-

ation suggested to them that there was more than an
ordinary saturation of aliphatic double or triple bonds
in the vitamin K molecule.

'I'hey found that the material

is non-nitrogenous and contains an aromatic nucleus; no
phosphorous or sulfur is present in the structure.

They

concluded from their work that the properties of vitamin
K are consistent with those of a complex, unsaturated
hydrocarbon.
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2. Isolation of vitamin K.

In the spring of 1935, it be-

came apparent that more than one compound possesses vitrunin K activity.

McKee and his coworkers (46) reported

the isolation of vitamins Kl and K2 from alfalfa and
putrified fish meal respectively, and they presented
evidence to indicate a quinoid structure for these vitamins.

This work was repeated in the same laboratory

shortly after by Binkley (47), and the previous findings
were substantiated.
Almquist and Klose (48) recently have reported that
phthiocol, the chemical formula of which is 2-methyl-3hydroxy-l, 4-naphthoquinone, possesses physical and chemical properties similar to pure vitamin K.

It has been

shown by these men that phthiocol is effective in preventing the hemorrhagic diathesis in chicks subsisting
on a K-deficient diet when given at levels of 20 mgm.
per kilogram of diet.

They have also suggested that

phthiocol is the simplest member of a homologous series
of antihemorrhagic substances.

Later these investiga-

tors (49) reported that the antihemorrhagic activity of
phthiocol lay somewhere between that of methyl naphthoquinone and hydroxy naphthoquinone.

Their study in-

dicated that the methyl group was functionally important
whereas the hydroxyl group seemed to reduce activity.
They agreed that the activity of phthiocol is lower than
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the more complex form of vita.min K existing in alfalfa.
Ansbacher and Fernholz (50), in their study of this compound, were of the same opinion.
Recently Thayer and his associates (51), as well as
MacCorquodale and his coworkers (52), working in Doisy 1 s
laboratory at St. Louis University Medical School, have
found 2-methyl-1,4-naphthoquinone the most active compound studied, but when this comnound was compared with
the natural vitamins Kl and K2, its activity was relatively insignificant.

They believed the structure of

the vitamin Kl molecule to be 2-ethyl-3-phytyl-1,4naphthoquinone.

Fieser and his coworkers (53) suggested

that the structure of Kl was 2,6(?)-dimethyl-3-phytyl-l,
4-naphthoquinone or the 2-mono-methyl compound.

From

the study of less complex models, Fieser, Campbell and
Fry (29) favored the latter structure.
Further study by Binkley and collabors.tors (54) indicated that vitamin Kl is 2-methyl-3-phytyl-1,4naphthoquinone.

The final step in the proof of this

structure of vitamin Kl was the synthesis of the compound in three separate laboratories practically simultaneously, by Almquist and Klose (55), MacCorquodale and
associates (56), and Fieser (57).

'lhe natural and syn-

thetic products had the same physical and chemical properties and approximately the srune antihemorrhagic potency.
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This comparison with the synthetic product shovrnd conclusively that the structure of the vitamin isolated
from alfalfa was 2-methyl-3-phytyl-1,4-naphthoquinone.
Vitamin K2 was isolated from putre.fying fish meal
by MacCorquodale (42), McKee (58) and their associates
by methods similar to those used for the isolation of
vitamin Kl.

This vitamin compound was obtained as light

yellow crystalline plates with a melting point of 53.554.5 degrees Centigrade.

The potency of vitamin K2 is

60 per cent that of vitamin Kl; that is, approximately
600 Thayer-Doisy units per mgm.

Although vitamin K2 has

been isolated, its structure has not been identified.
The data of McKee and coworkers (58) indicnte that it
also is a 2,3-disubstituted-1,4-naphthoquinone.

Fieser

and coworkers (29,53), on the basis of the chemical and
physical properties reported by McKee and associates
(58), postulated the structure 2,3-difarnesyl-1,4naphthoquinone.
3. Vitamin K activity of simple quinones and related
products.

Almquist and Klose, in June 1939 (48) report-

ed the first completely identified form of vitamin K.
This compound is phthiocol (2-methyl-3-hydroxy-1,4naphthoquinone) and might be termed vita.min K3.

In con-

trast to many vitamin K preparntions, phthiocol is
slightly soluble in water.

Although the compound does
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possess vitamin K potency, its activity is not comparable with that of the vitamin from alfalfa.

Experiment-

ally, Almquist (48) has shown that a 0.2 per cent
buffered solution of phthiocol is effective in curing
K-deficient chicks when given by mouth, intramuscularly
or intravenously.
Another synthetic naphthoquinone which has been
studied extensively is 2-methyl-1,4-naphthoquinone, or
vitamin K4.

Amsbacher and Fernholz (50,59) showed that

this comnound possesses activity of the same order as
vitamin Kl.

All other members of this group which have

been tested are less than 1/20 as active as vitamin Kl.
Most of the active synthetic compounds a.re basically 1,4-naphthoquinones or the corresponding hydroquinones; a few, however, are not (30).

Many of the

1,4-naphthoquinone compounds are inactive.

Ansbacher

and Fernholz (59) have shown that often relatively minor
changes in the substituent groups of very active compounds of this type may completely eliminate their vitamin activity.

'Illus, 2-methyl-1,4-naphthoquinone is

very active, the 2-ethyl compound show much less activity, and the 2-propyl compound is inactive.

Ansbacher

(59) states that although the number of naphthoquinones
which could be tested for vitamin K activity could be
greatly increased, from results of his investigation
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it does not appear liKely that the preparation of such
compounds would lead to the discovery of a substance
surpassing in activity 2-methyl-1,4-naphthoquinone.
A complete list of the synthetic compounds, including vitamins Kl, K3, and K4, with their respective
formulae and activity expressed in units per milligram,
has been published recently by Brinkhous (30) in a summary of vitamin K compounds.
-Clinical Causes of Deficiency in ProthrombinIn order to better understand the development of
clinical study of hypoprothrombinemia, it will be well
to summarize briefly the sequence of experimental investigation of vitamin K deficiency.
That a vitamin K deficiency exists in cases of obstructive jaundice and bilia!"J fistula was suggested for
the first time in 1937 (10) on theoretical grounds.

~he

evidence then available indicated that (1) a hypoprothrombinemia exists in obstructive jaundice (19), biliary fistula (20,21,22), and vitamin K-deficient chicks
(8,9,10); (2) that vitamin K is a fat-soluble vitamin,
(3) that certain of the other fat-soluble vitamins, A
and D, require, as fats do, the presence of bile or bile
salts in the intestine for their adequate absorption
(60,61), and (4) that the low prothrombin level and the
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hemorrhages can be prevented or cured in biliary fistula
dogs by feeding bile (20).

It was clear that cases of

bleeding in biliary fistula or in obstructive jaundice
have in connnon the absence of bile in the intestine and
that the bleeding tendency in each is due to a diminished plasma prothrombin.

On the basis of these facts,

Quick (10) postulated, in addition, that they have a
vitamin K deficiency, due to the lack of bile in the intestine.
With the stage thus set by the investigations referred to in the preceding paragraphs, it was only logical to make the next move; namely, the study of the
effect of vitamin K in obstructive jaundice and other
diseases of the biliary tract.
1. Obstructive jaundice and biliary fistula.
In October, 1937, Greaves and Schmidt experimented
with bile fistula and jaundiced rats and presented the
first evidence to support the earlier theory of Quick.
They produced a hemorrhagic state in these animals by
prolonged feeding with a low fat diet and observed a
marked increase in the coagulation time of the blood
when the prothrombin level had been reduced to 20 to 30
per cent of normal.

Bile feeding, as was earlier demon-

strated by Hawkins and Brinkhous (20), corrected the low
prothrombin levels.

They also found that the ad.minis-
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tration of crude extracts of vitamin K, prepared from
alfalfa, resulted in prompt decrease of the coagulation
time of the blood and increase of the prothrombin level.
Further studies in June of 1938 by Smith, Warner, Brinkhous and Seegers (21} showed that bile alone was much
less effective in raising the plasma prothrombin level
than a preparation containing a combination of vitamin K
and bile or bile salts.
without effect.

Vitamin K alone was practically

The equal effectiveness of bile or bile

salts in the absorption of vitamin K indicated that the
latter was the active material in bile (21,22,23).
The first report of vitamin K therapy for human
cases of obstructive jaundice and biliary fistula came
from Warner, Brinkhous and Smith in January, 1938 (26).
While observing their jaundiced cases over a period of
ti~e,

they fo1.llld that many showed no bleeding tendency,

and in them the prothrombin level was usually above 50
per cent of normal.

When the prothrombin level fell

below 35 per cent, as it frequently did in this series
of cases, they enco1.llltered bleeding from mucous membranes or hemorrhage at operation or from the wound
af'tcr operation.

The restoration of bile to the intest-

inal tract led to a gradual rise in the prothrombin
level, requiring, on an average, a period of two weeks
to attain normal level.

This was shown in cases where
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the obstruction was suddenly released, or in cases where
bile was fed by mouth.

On the other hand, a vitamin K

concentrate prepared from alfalfa, plus human bile or
bile salts, led to a rise in prothrombin from 20-40 per
cent to 85-105 per cent of normal in six to eight days.
It was concluded that these jaundiced patients undoubtedly suffer from disturbances in the digestion and absorption of fats, which in turn causes a vitamin K deficiency characterized by hemorrhagic tendencies.
Further evidence of the beneficial effects of vitamin K in obstructive jaundice crune practically sinmltaneously from Butt, Snell and Osterberg of Mayo Clinic
in February of 1938 (27,62) and from Dam and Glavind of
Copenhagen in March of 1938 ( 63) •
Snell (62) submitted a report on a patient who had
obstructive jaundice due to stricture of the common bile
duct, a badly damaged liver and a virtually incoagulable
blood.

This patient had failed to respond to the usual

methods of treatment for the hemorrhagic diathesis of
jaundice and was subsequently given a mixture of dried
alfalfa and bile salts by mouth.

The coagulation time

of the patient's blood was thereupon greatly shortened
and for a time it was hoped that surgical treatment
could be attempted; however, the patient soon failed to
tolerate this m:txture and the blood returned to its in-
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coagulable state.

Snell believed this case to be analo-

gous to the experimental dogs of Smith, Warner and
Brinkhous (25), in which they caused a liver necrosis
by chloroform intoxication and noted a decreased plasma
prothrombin with hemorrhagic tendencies.

Snell believed

that there was some justification for concluding that
(1) the hemorrhagic state in jaundice is attributable to
a deficiency of prothrombin which in turn is due to
failure of absorption or utilization of some substance
normally present in the diet which requires bile for its
absorption; that (2) this substance may be the coagulation vitamin (vitamin K); and that (3) additional toxic
factors may deplete the supply of prothrombin from the
liver, as in necrosis of the liver caused by chloroforru.
Butt, Snell and Osterberg administered vitamin K
and human bile or animal bile salts to 18 patients who
had obstructive jaundice, and obtained good results in
every case.

In most of these 18 cases complete biliary

obstruction and subsequent damage to the liver were
present.

In several cases the prothrombin time was not

elevated greatly but vitamin K and bile salts were administered as a prophylactic measure.

An

example of the

prophylactic use was a case of stricture of the common
duct and jaundice.

The patient had had a severe hemor-

rhage following a previous operation elsewhere for this
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condition.

Although her prothrombin time was nearly

within normal limits, vitamin K and bile salts were
given as a precautionary measure.

This patient went

through her operative procedure at the clinic without
any abnormal bleeding and, although she later died from
a hepatic insufficiency, no abnormal bleeding was noted
at necropsy.
In the same study, Butt, Snell and Osterberg (27)
pointed a case which they believed was typical of the
usual course in a case of obstructive jaundice.

In

spite of repeated transfusions of blood the prothrombin
time increased gradually to 140 seconds over a period of
two weeks and remained elevated until death.

At necrop-

sy a large amount of blood was found in the gastrointestinal tract and in the peritoneal cavity.
In three cases of obstructive jaundice, these men
found a rapid decrease of prothrombin time following the
administration of vitamin K and bile salts which was
rather striking.

In one case a definitely dangerous

prothrombin time was reduced to normal limits over a
period of three days with the use of vitamin K and bile
salts.

Vitamin K alone was given to one case for nearly

a week without any significant effect of the prothrombin
time.

However, 24 hours after bile was added to the K

intake, there was a marked fall in the prothrombin time.
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In one case in which the patient was eating heartily
and the prothrombin time was nearly double the nor:nal
value, administration of human bile alone resulted in
an immediate fall in the prothrombin time.
Butt, Snell and Osterberg (27) calculated the dose
of vitamin K required by man by comparing the body
weight and the weight of the intake of food to that of
a chick for which they knew the dose necessary to prevent hemorrhage.

They found that, theoretically, 23 mg.

of their material should be an adequate daily dose for
man, but they gave orally in capsules 200 mg. daily,
which is nearly ten times the calculated dose.

In order

to facilitate the absorption of this dosage of vitamin K,
they gave whole human bile or rather large doses of bile
salts ( 1000 to 4000 mg. of

11

Bilron Lilly 11 daily).

Human

bile was mixed with pineapple juice and administered in
doses of 75 to 150 cc. orally before each meal.
Dam and Glavind {63), in their first report of vitamin K therapy, treated five patients with obstructive
jaundice.

Two of the cases had carcinoma of the pancreas

which was causing pressure on the biliary tract and thus
obstruction.

All of the cases had increased clotting

values and increased prothrombin times (high R-values).
The parenteral introduction of 15 mg. of vita.min K daily
rendered the clotting power of the blood normal in from
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six to eight days and the prothrombin times returned to
nearly normal values in the same time.

It was conclud-

ed that the increased clotting time before the introduction of vitamin K was due to reduced absorption of
the vitamin from the intestine.
Another report in 1938 by Brinkhous, Smith and
Warner (64) confirmed the original finding of a prompt
rise in the prothrombin level following vitamin K therapy in jaundiced patients.

They made a study of 27

cases of obstructive jaundice, in most cases of which
the plasma prothrombin levels were definitely below
normal.

In this series six cases showed a definite

bleeding tendency and in every instance was associated
with a marked decrease in the prothrombin level, usually
to less than 35 per cent of normal.

One case of biliary

fistula responded to bile feeding alone with a gradual
rise of prothrombin to a nearly normal level over a period of six weeks.

In marked contrast to this was the

very rapid rise in prothrombin level which occurred in
obstructive jaundice cases receiving bile and alfalfa
extract together.

It was also noted that the amount of

lowering of prothrombin is not clearly dependent upon
the intensity or duration of the jaundice.

In two cases

of obstructive jaundice receiving vitamin K and bile
therapy, the prothrombin rose rapidly during periods of
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increasing jaundice, indicating that the jaundice itself
is not the essential factor.

Two patients of the entire

series, one with a biliary cirrhosis of three years duration and another with a far-advanced malignancy of the
liver, did not respond to alfalfa therapy.

These men

concluded that the failure of these two cases to respond
suggests that in addition to certain dietary essentials,
a liver of good functional capacity is needed for the
manufacture of prothrombin.
Snell, Butt and Osterberg (65} made a second report
in November of 1938 on the successful use of vitamin K
in obstructive jaundice, in which they used alfalfa as
the source of vitamin K rather than putrefying fish meal
as in their earlier studies.

They found that their

original concentrates of vitamin K from putrefied fish
meal lost a large part of their potency when allowed to
stand at room temperature or in an icebox for 30 to 90
days, and, in an effort to find a more stable concentrate of

vita.~in

practical source.

K, they selected alfalfa as the most
With the cooperation of the Abbott

laboratories, they obtained rather large quantities of
concentrate of vitamin K which had been extracted from
alfalfa with petroleum ether.
potency of 20 mg. or less per

This preparation had a
kilogra~

of chick diet as

measured by the prophylactic chick method, and 200 mg.
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of the concentrate was equivalent to approximately 66
grams of dry alfalfa meal, or approximately 37,500 DamGlavind units.
They reported 13 cases of actual bleeding in obstructive jaundice which were controlled by

acL~inister

ing this vitamin K concentrate from alfalfa in combination with bile salts.

In another large group of jaund-

iced patients, an elevation of the quantitative level of
prothrombin in the circulating blood and a reduction in
the elevated prothrombin clotting time was effected by
this therapy.

When the concentrates were ad.ministered

orally to 28 patients before and after surgery, none
bled seriously and there were no deaths from hemorrhage.
They observed this to be in marked contrast to 14
patients who received no concentrate of vitamin K or
bile salts preoperatively, 64 per cent of whom bled
after surgery.

They concluded that although concentrate

of vita.min K obtained from alfalfa was at that time still
an empiric therapeutic aid, yet with bile salts it had
effectively prevented and controlled the hemorrhagic
diathesis in cases of obstructive jaundice and deserved,
therefore, a more extensive clinical use.
Snell, Butt and Osterberg have reported that the
greatest danger of hemorrhage following surgical operation for the relief of obstructive jaundice is between
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the third and the ninth day after operation (66); and
this usually may be detected by a rise in the prothrombln time, which seems to occur with considerable
regularity after operation.

They observed that the ef-

fect of operation is often sufficient to decrease the
concentration of prothrombin in the plasma below the
critical level, with a corresponding rise in the prothrombin time.

Whether this is a result of injury of

the liver resulting from anesthesia or is due to the
loss of blood at operation, they were unable to say.
In their experience, postoperative bleeding may begin as
a slight oozing from the wound or gums, or as hematemesis or melana; it also may become generalized and
severe with very little warning.

Under such circum-

stances transfusions of blood are indicated; their effect is to supply a small quantity of prothrombin for
emergency use, which exerts its effect for only 6 to 12
hours, if at all.

During this interval, the administra-

tion of vitamin K and bile may be

resUi.~ed,

preferably by

means of the intragastric or duodenal tubes.

In add-

ition to these two forms of treatment, the importance of
beginning an adequate food intake as soon as possible is
obvious since the reestablishment of normal biliary flow
into the intestine and the restoration of a normal state
of nutrition are the ultimate considerations required
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for cure of the hemorrhagic state.
In 1939 there were a large number of reports on the
successful use of vitamin K therapy in the bleeding
tendency and hypoprothrombinemia in patients with obstructive jaundice.

Olson (67) reported a case of ob-

struction of the connnon bile duct which was operated and
was treated preoperatively with intravenous glucose and
a blood transfusion.

Unusual bleeding was encountered

at the time of operation and oozing occurred for several
days after the operation.

Six days after operation a

severe hemorrhage occurred, was controlled by a blood
transfusion, but the ozzing recurred, and four days
later another serious hemorrhage requiring blood transfusion again occurred.

Prothrombin bleeding time by the

method of Quick was 200 seconds, whereas the normal is
20 to 30 seconds.

Vitamin K and bile salts were immedi-

ately given: 2 capsules orally t.i.d. after meals, accompanied by a 5 gr. tablet of bile salts.

Prothrombin

bleeding time three days later was 120 seconds, no
further hemorrhqge had occurred, and oozing from the
wound was decreasing.

Seven days after the administra-

tion of vitamin K was instituted, the prothrombin bleeding tLme was reduced to 38 seconds, which was comparable
to a normal control, and all bleeding had stopped.
convalescence from that time was uneventful.

The
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The case just cited, as reported by Olson (67), is
typical of addi t:tonal reports made in the past two years
on the continued successful use of vitarain K in patients
with obstructive jaundice.

Such reports have been made

by Butt, Snell and Osterberg (68,69,70), Smith, Ziffren,
Owen and Hoffman (71), Stewart and Rourke (72,73) and
Scanlon, Brinkhous, Warner, Smith and Flynn (74).
In addition to the studies of vitamin K deficiency
in patients with obstructive jaundice, a number of similar studies have been made of patients with a biliary
fistula.

One of the first such cases reported, from

the laboratory of Brinkhous, Smith and Warner (26,64) at
the University of Iowa, had a complete external fistula
and a hypoprothrombinemia and a bleeding tendency.

With

feeding of whole bile, the prothrombin level returned
from a low level of 27 per cent of normal to 89 per cent
of normal.

In this case the vitamin K intake in the

food was sufficient, though not determined, and the addition of bile was necessary to permit absorption of the
vitamin present.

Successful treatment of the hypopro-

thrombinemia in these patients has been reported also by
a number of other investigators including Butt, Snell
and Osterberg (65), Stewart (75), Stewart, Rourke and
Allen (72) and Smith, Ziffren, Owen, Hoffman and Flynn
{ 74).
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It has been reported that the administration of
vitamin K in obstructive jaundice is less effective when
the prothrombin deficiency is associated with extensive
hepatic damage (25,73).

That this is true was confirmed

by two independent studies conducted in September of
1940.

Bollman, Butt and Snell (76} produced hepatic

damage in rats by uniform exposure to a known concentration of carbon tetrachloride.

Grude concentrates of

alfalfa and 2-methyl-1,4-naphthoquinone were administered to some of these animals and in all instances failed
to increase the level or prothrombin in the circulating
blood.

The only factor found was that extensive hepatic

injury was associated with depletion of the level of
prothrombin and also with failure of res1)onse to vitamin
K.

However, they did observe that in such animals

prompt recovery occurs when the hepatotoxic agent is removed and the liver repair is rapid.

They concluded

that the failure of vita.min K to maintain the prothrombin
level of the blood and the rapid recovery to nonnal after
discontinuation of exposure to the hepatotoxic agent indicates that the liver is of fundrunental importance in
the formation of prothrombin

and in the metabolism of

vitamin K.
Cullen, Ziffren, Gibson and Smith (77) extended the
study of liver intoxication, and its effect on plasma

-46-

prothrombin, to human beings.

They made determinations

of prothrombin levels of patients under chloroform,
ether and cyclopropane anesthesia.

A group of 6 cases

was operated for minor surgical complications under the
chlorofonn anesthetic.

Prior to operation the pro-

thrombin levels were within normal range in all cases.
Following operation there was a fall in every case with
a variation of from 11 to 40 per cent and an average
fall of 18 per cent.

Neither ether nor cyclopropane

produced any such in the uncomplicated cases which they
reported.

It was concluded that the normal functioning

liver is essential to maintenance of prothrombin in the
circulating blood, but the fall in the plasma prothrombin level which occurs after operation in patients
with obstructive jaundice or biliary fistulas is evidently due to factors other than the anesthetic agent
itself.
It had been recognized for years (65) that the
bleeding tendency in obstructive jaundice is often observed within the first few days postoperatively.

Al-

though often there would be no evidence of excessive
bleeding at operation, hemorrhage might be massive and
fatal within the next few days after operation.

Butt,

Snell and Osterberg (65) described eight patients with
prolonged plasma

prothro~bin

times and postoperative
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hemorrhage.

The bleeding occurred in each caae between

the first and fourth postoperntive days.

In a few pat-

ients, hemor1"hage was not observed until later.
The common occurrence of cholemic bleeding in the
first few days postoperatively led to a careful study
of the plasma prothrombin during this critical period.
Butt, Snell and Osterberg (65,69) observed a prolongation of the plasma prothrombin time with considerable
regularity in these patients following operation.

Those

patients in whom considerable liver damage in addition
to obstruction of the biliary ducts was noted at the
time of operation appeared to be most susceptible to
postoperative hemorrhage.

Stewart, Rourke and Allen

(72) studied tha plasma prothrombin level following
surgery in a group of 19 patients with obstructive
jaundice.

Uniformly, they :round a fall in prothrombin,

despite the fact that a blood transfusion was given
routinely at the time of operation.

This fall averaged

20-25 per cent, and the minimum level was reached most
connnonly between the first and fourth days, coinciding,
thus, with the time hemorrhage most frequently occurs.
A number of causes for this fall in prothrombin
after operation have been suggested.

The fact that the

fall of prothrombin in obstructive jaundice and biliary
fistula cases is partially due to a deficiency of vita-
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min K as a result of absence of bile in the intestine
has been adequately established by numerous studies
(21,23,27,64).

The influence of anesthesia in causing

postoperative decline in prothrombin level has apparently been minimized through the study of Cullen and his
associates (77).

Other suggestions (64) which have been

made include (1) increased consumption of prothrombin
due to hemorrhage and exudate formation, without adequate reserves of prothron1bin or vitamin K to restore
the prothrombin level promptly; (2) a low bile salt output by the liver and consequent malabsorption of vitamin
K for a period after the obstruction has been relieved;
and (3) liver damage by infection or operative trauma,
and decreased production of prothrombin by the liver.
Brinkhous, Smith and Warner (64) believe that because
of these variable

f~ctors

some patients somewhat above

the bleeding level before operation must be considered
as potential bleeders, and must be treated accordingly.
From the numerous studies on the vitrunin K deficiency and hypoprothrombinemia in obstructive jaundice and
biliary fistula, it is apparent that the bleeding tendency can be prevented, and in many cases it can be cured
by treatment with vitamin K.

Butt, Snell and Osterberg

(69) have stressed the importance of preoperative and
postoperative administration of vitamin K to avoid the
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serious bleeding which may occur at the time of operation or soon thereafter.

They administer the vitamin

for several days prior to operation and continue this
therapy for several days after operation, the time depending on the rate of decline of the prothrombin time
of the blood.

They state that no matter what method of

administration is used, or what concentrate of vitamin K
is used, the importance of anticipating the danger of
prothrombin deficiency and detecting it by laboratory
studies will remain a prime consideration in successful
treatment.
Many different sources of vitamin K have been used
in the treatment of the vitamin deficiency in obstructive, but at present the medicinal products are of two
types.

One is an extract of alfalfa and contains the

fat-soluble natural vitamin K.

The other represents a

group of synthetic products which are more or less effective, the base being naphthoquinone.
Dam and Glavind (63) reported the treatment of five
cases of obstructive jaundice with K-avitaminosis by
intramuscular injections of an emulsion of vitamin K in
water and found it possible to resto1 e the blood caog1

ulation to the normal value within a week.
Since then Tage-Hansen (78) has studied the effect
of vitamin K when given perorally, intramuscularly and
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intravenously.

For peroral use gelatin or starch cap-

sules containing the concentrate together with desoxycholic acid were prepared.

Normal coagulation was ob-

tained within two days with doses of from 100,000 to
200,000 Dam units of vitrunin K plus 2 gm. of desoxycholic acid.

For injection purposes, concentrEctes hav-

ing a strength of more than one million units per gram
were used.

Intramuscular injection on two successive

days of a watery emulsion of such a preparation representing 150,000 units of vitamin K resulted in normal
coagulation three days after the f'irst injection.

The

intramuscular injection of' an oil solution of the vitamin in a one day or in a three to five day period led to
restoration of normal blood coagulation after one to two
weeks, from 150,000 to 400,000 units in all being used
for each patient.

Intravenous injections of emulsions,

from 15,000 to 30,000 units in one dose, yielded normal
blood coa5-u.lation within eighteen hours, but the effect
persisted for only a few days.

Tage~Hansen

concluded

that in urgent cases it is a great advantage that two
rapidly acting forms of application are now available:
intravenous injection and ingestion together with bile,
of which the first is the most efficient.
Butt, Snell and Osterberg (65,69) have also used
intramuscular injection of vitamin K in a few cases.
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They administered the vitamin in peanut oil intramuscularly, but observed no constant prothrombin response with this therapy as did Tage-Hansen and Dam and
Glavind.

From their experience with this method, Butt

and his associates concluded that the intramuscular administration of vitamin K is not practical when immediate resnonse is desired in serious hemorrhage.

However,

they believed that this method might be practically employed in cases of obstructive jaundice which require
prolonged vitamin K therapy.
The first reported use of intravenous therapy of a
known vita.min K preparation was by Smith and coworkers
(71) and practically simultaneously by Butt, Snell and
Osterberg (68).

Taey demonstrated that phthiocol, one

of the synthetic quinone compounds, was very effective
in doses of 40-100 mgm.

A rise in prothrom.bin was ob-

served in less than 24 hours in all the cases studied.
No toxic actions have been reported by either group of
workers.

Snell and Butt (37) made similar observations

with intravenous injections of 5-10 mgm. of 1,4-dihydroxy-2-methyl-3-naphthaldehyde.

This route appears to

be ideal, especially in those cases in which there is
nausea and vomiting, or in which there is interference
with absorption from the intestine.
In the past year there have been several reports of
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the continued successful use of the na.phthoquinone compounds in the therapy of obstructive jaundice.

Butt,

Snell and Osterberg (70) reported the oral and intravenous administration of 2-methyl-1,4-naphthoquinone, a
compound which has been considered the most potent of the
quinone group, practically as active as vitamin K itself.
In most instances 1 or 2 mgm. of the substance with 5 or
10 grains of animal bile salts constituted an adequate
daily dose.

Except in cases of liver damage, the ele-

vated prothrombin clotting time was found to return to a
normal value within twelve, twenty-four, or thirty-six
hours following the administration of this compound by
mouth.

Being insoluble in water, the compound was used

intravenously by suspending it in a physiologic solution
of

sodiu.~

chloride.

It was found that 1 mgm. doses

daily by this route was effective in reducing the elevated prothrombin clotting time.
A similar study has been CTade by Rhoads and
Fliegelman (79) in which eight cases of obstructive
jaundice and two cases of hemorrhage of the newborn have
been treated successfully with 2-methyl-l,4-naphthoq1J.inone.

The compound was ad.rninistered orally in doses

of from 1 to 4 mgm. daily.

In three cases hemorrhagic

phenomena occurred before the first dose was given, but
in all three the hemorrhage was controlled.
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Recently Andrus and Lord (80) have reported their
experience with the intramuscular injection of 2-methyl1,4-naphthoquinone in oil for the treatment of jaundiced
patients.

The preparation which they have prepared con-

tains the K-active compound dissolved in corn oil, each
cubic centimeter containing 1 mgm. of the active substance.

Twenty-eight patients with initial prothrombin

levels of from 5 to 70 per cent of normal were treated,
the adults receiving 2 mgm. and the infants receiving
0.35 to 1 mgm. of the compound intramuscularly.

In many

cases single injections of this compound restored the
level of plasma prothrombin by as much as 48 per cent,
and the effect was evident as early as eight hours after
injection.

It was also noted that the effect of a single

injection may be prolonged for as long as a week, unless
adverse factors such as operations on the biliary tract
or other liver damage supervened.
Another report of the use of 2-methyl-1,4-naphthoquinone in hypoprothrombinemia was submitted by Norcross
and McFarland (81) in December of 1940.

'l'hey administer-

ed this compound intravenously to 22 patients and found
it to be efficient in raising the prothrombin level by
this route.

The minimal effective dose of 2-methyl-l,

4-naphthoquinone was found to be 2 mgin., and this dose
given intravenously raised the prothrombin level from 50
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per cent to 80 per cent in an average of seven and onehalf hours and to 100 per cent in an average of twenty
hours.

Further, a 2 mgm. intravenous dose kept the pro-

thrombin level above 90 per cent of normal for four or
more days unless liver damage was present.
It seems apparent from these more recent reports
of the success.ful treatment or hyPoprotlFombinemia in
obstructive jaundice with intramuscular and intravenous
naphthoquinones, that the parenteral administration of
these substances will eventually be generally adopted
as the proper therapy for the hemorrhagic diathesis
associated with this disease.
2.

Hemorrhagic disease of the newborn.
Low and variable plasma prothrombin levels in the

newborn and in early infancy, and the presence of an
extreme hypoprothrombinemia in hemorrhagic disease of
the newborn were recognized in 1937 by Brinkhaus,
Smith and Warner (82).

Since then, further studies of

the low prothrombin level in normal infancy have indicated a possible relation to a vitamin K deficiency.
Brinkhous, Smith and Warner found the prothrombin
level of the newly born to vary considerably in different infants and in the same infant at different ages.
These workers have further shown that for normal newly
born infants the prothrombin values varry from 14 to 39
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per cent of the level found for normal adults, while in
a case of hemorrhagic disease the prothrombin level was
extre~ely

low, in fact less than 5 per cent of the adult

norm (82).
With this work in mind, Waddell and Guerry (83)
postulated that vitamin K might conceivably be effective
in raising the prothro!nbin content of the newly born
infant's blood and thereby prevent both spontaneous
hemorrhage or that initiated by the traUina of labor.
IJhey made a study of the blood clotting times and the
prothrombin clotting times of twenty newly born infants.
For ten control infants the prothrombin clotting time
and the clotting time of the blood were determined at
varying intervals during the first week of life.

To ten

other infants vitamin K concentrate (Abbott) was administered orally, at the end of 24 hours 1 cc., at the end
of 48 hours 0.5 cc. and at the end of 72 hours 0.5 cc.
From a study of the prothrombin clotting rate at various
intervals in the first week of life for the ten control
infants, they concluded (1) that the blood of newly born
inf ants differs markedly as regards the prothrombin
clotting time, unusually high rates being conrr.1on, (2)
that the blood of individual infants varies markedly on
different days of life as regards the prothrombin clotting time, (3) that the blood of certain infants is
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peculiarly deficient in

prothro~bin

as determined by the

prothrombin clotting rate and that the period of most
marked deficiency is between the ages of 48 hours and
72 hours and (4) that after the fifth day the rate tends
to fall to an apparently common level.

They believed

that the last fact strongly suggests a relationship between hemorrhagic disease of the newly born and the prothrombin content of the blood, in that hemorrhagic disease rarely occurs after the fifth day of life, the time
at which the prothrombin clotting rate of the control
infants appeared to approach a common level.

Tile most

important point in this study was brought out by a comparison of the blood clotting times and prothrombin clotting times of the control group and the vitamin K treated
group in the first week of life.

The generally lower

clotting values and their strikingly common level for
the treated infants was very evident.

Waddell and

Guerry concluded from this study that the prevention and
treatment of spontaneous hemorrhage, concealed or apparent, associated with a high prothrombin clotting and
blood clotting time and appearing within the first week
of life, should be easily effected with vitamin K.
Hellman and Shattles (84) and Shattles, Delfs and
Hellman at Johns Hopkins Hospital confirmed the finding
of a low

prothror~bin

level at birth.

Cord blood, in
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their series, contained about 22 per cent as Im1Ch prothrombin as in the mother's blood.

Shettles, Hellman

and Delfs (85) also have studied a total of 17 premature
infants and have found the average prothrombin level to
be only about one-third that of full-term infants; that
is, less than 10 per cent of the values of the mothers.
Having established the efficacy of vita.min K therapy in the hypoprothro,:ibinemia of the newborn, Hellman,
Moore and Shettles, in June of 1940, made a study to
compare the ability of various naphthohydroquinone derivatives in raising the plasma prothrombin levels of newborn infants when fed to their mothers during labor.(86)
For this purpose they used the following synthetic compounds:

(1) 2-methyl-1,4-naphthoquinone, (2) 2-methyl-

3-phytyl-1,4-naphthoquinone and (3) 2-methyl-1,4-naphthohydroquinone dipropionate.

In 2000 unit doses, these

three synthetic comDounds given by mouth, and one given
intravenously, were shown to elevate significantly the
infant plasma prothrombin level when given to the mothers
during labor.

They found that the infant plasma pro-

thrombin was raised to the highest level by the administration of the substance having the simplest chemical
structure; namely, 2-methyl-l, 4-naphthoquinone.

'I'his is

is in agreement with previous studies in which the hypoprothrombinemia of jaundice was treated with quinones.
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More recent studies of vitamin K therapy in the
treatment of hemorrhage of the newborn have confirmed
the previous reports of successful prevention of dangerously low levels of plasma prothrombin.

Reports by

Poncher and Kato (87), Waddell and Lawson (88), Maumence,
Hellman and Shettles (89), Lawson (90) and Kato and
Poncher (91) all indicate that the treatment of hypoprothrombinemia. of the newborn, particularly in cases of
apparent hemorrhage, is rapidly becoming an accepted
measure of therapy.
3. Other conditions.
Recently, Sprue and Hemophilia have been considered
as conditions in which vitamin K therapy might be indicated.

All that needs to be said in regard to this

possibility is that many of the investigators already referred to in previous sections have found no indications
for vitamin K therapy for these diseases up to the present time.
-ConclusionVitamin K, a fat-soluble vitamin, is essential for
the maintenance of a normal concentration of prothrombin
in the blood.

Animal experimentation and clinical studies

have shown that certrrin hemorrhagic tendencies are due to
a low plasma prothrombin resulting from a vitamin K

de~
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ficiency •

Absorption of this fat-soluble vitamin is

dependent on the presence of bile in the intestine
rather than on the adequacy of vitamin K in the diet.
Lowered prothrombin concentration may occur in conditions in which extensive intestinal lesions interfere
with absorption or, more frequently, in conditions in
which bile is excluded from the intestine by obstruction
of the common bile duct.

In such cases the administra-

tion of vitamin K will restore the normal prothrombin
level.

Bile salts, of course, must be given along with

the orally administered vitamin in cases in which bile
is not present in the intestine; otherwise the vitamin
will not be absorbed.

Recent work also indicates that

newborn infants have a vitamin K deficiency in the first
few days of life and that the administration of vitamin
K will prevent and cure the hemorrhe.r;ic diathesis in at
least many cases of hemorrhagic disease of the newborn.
More generally, it is safe to say that vitamin K
therapy is only indicated in those conditions of hemorrhage or potential hemorrhage in which there is definite
hypoprothrombinemia.

Prothrombin metabolism is inter-

fered with when:
(1).

Vitamin K is inadequate in the diet.

( 2).

Bile is not pre sE;nt in the upper intestinal
tract.
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(3).

Fat digestion is interfered with.

(4).

Normal mucosa of the upper intestinal tract
is destroyed.

(5).

Liver function is interfered with.

When the above conditions are responsible for a hypoprothrombinemia, then vitamin K and bile are indicated.
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